治療性肉毒桿菌毒素的全球市場：Medtech 360

全球 BTX 治療程序量以及產品銷售和收益預計將受到現有患者重返接受維護程序的需求以及隨著罕見適應症擴大而增加的新患者需求的支持。

新適應症的核准和現有適應症的擴展將是治療性 BTX 市場的關鍵驅動力。

全球 BTX 治療市場日益整合。

市場規模和成長因地區而異，但美國市場是全球成長最快的。

本報告研究分析了全球治療性肉毒桿菌毒素市場，並提供了2019年至2033年市場格局的全面資料和分析。

目錄

世界

摘要

執行摘要

• COVID-19 最新訊息
• 市場亮點
• 競爭亮點
• 市場開發
• 目標區域
• 目標程式
• 目標產品

主要報告更新

全球肉毒桿菌素治療市場

• 市場亮點
  • 主要內容更新
• 市場定義
• 市場預測資料
• 市場佔有率
• 競爭考察
  • Allergan (an AbbVie company)
  • Merz Pharma
  • Ipsen
  • GlaxoSmithKline
  • Supernus Pharmaceuticals
  • 其他主要競爭對手
  • 影響所有衝突的因素
• 市場趨勢

美國治療性肉毒桿菌毒素市場

• 市場亮點
  • 主要內容更新
• 市場定義
• 市場預測資料
• 市場佔有率
• 競爭考察
  • 美國治療性肉毒桿菌毒素市場的競爭考察
  • 影響所有衝突的因素

歐洲治療性肉毒桿菌毒素市場

• 市場亮點
  • 主要內容更新
• 市場定義
• 市場預測資料
• 市場佔有率
• 競爭考察
  • 歐洲治療性肉毒桿菌毒素市場的競爭考察

亞太地區治療性肉毒桿菌毒素市場

• 市場亮點
  • 主要內容更新
• 市場定義
• 市場預測資料
• 市場佔有率
• 競爭考察
  • 亞太地區治療性肉毒桿菌毒素市場競爭考察
  • 影響所有衝突的因素

附錄

調查方法

Global therapeutic BTX procedure volumes-and thus product sales and revenues-will be supported by the need for existing patients to return for maintenance procedures, as well as rising demand among new patients driven by expanding rare indications.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for therapeutic BTX in the US, Europe, and the Asia Pacific region from 2019 through 2033.

New indication approvals and existing indication expansions will be significant drivers in the therapeutic BTX market.

• Which indications contribute the most to growth, and which have the largest market growth potential?
• What regional differences exist regarding indication approvals, and what are the new indications approved in each region?
• Which competitors have been targeting these indications?
• Are there any significant changes in competitive landscape ?

Global therapeutic BTX markets are becoming increasingly consolidated.

• What are some key competitive strategies currently being leveraged or can potentially be employed to succeed in the market?
• How do the competitive landscapes differ by region, and what considerations must companies make in particular markets?

Markets vary greatly by region in terms of size and growth, with the US market experiencing the fastest expansion globally.

• What key drivers are contributing to each regional market's relative size and growth?
• How does pricing vary by region, and what factors most significantly affect pricing within each market?
• How does the reimbursement of therapeutic BTX products influence the pricing and adoption of these products across different indications and geographies?
• How are the increasing cases of different indication impacting the units sales and market values?

Table of Contents

Global

Abstract

Executive Summary

• COVID-19 Updates
• Market Highlights
• Competitive Highlights
• Market Developments
• Geographies Covered
• Procedures Covered
• Products Covered

Key Report Updates

Global Therapeutic Botulinum Toxin Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • Allergan (an AbbVie company)
  • Merz Pharma
  • Ipsen
  • GlaxoSmithKline
  • Supernus Pharmaceuticals
  • Other Key Competitors
  • Factors Affecting All Competitors
• Market Developments

US Therapeutic Botulinum Toxin Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • US Therapeutic Botulinum Toxin Market Competitive Insights
  • Factors Affecting All Competitors

European Therapeutic Botulinum Toxin Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • European Therapeutic Botulinum Toxin Market Competitive Insights

Asia Pacific Therapeutic Botulinum Toxin Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • Asia Pacific Therapeutic Botulinum Toxin Market Competitive Insights
  • Factors Affecting All Competitors

Appendix

• Abbreviations
• Bibliography

Methodology

• Core Country Coverage Methodology
• Research Methodology
• Marketrack Methodology
• PriceTrack Methodology
• Forecast Methodology
• Supplemental Country Coverage Methodology
• Base-Year Ratio Analysis
• Market Forecasting

Tables and figures

• Therapeutic BTX Market, by Region, Global (USD), 2019-2033
• Therapeutic BTX Market Landscape, Global (USD), 2023 and 2033
• Therapeutic BTX Revenue Market Share Rankings, by Region, Global, 2023
• Competitive Insights
• Companies Mentioned
• Recent Events in the Therapeutic BTX Market, Global
• Key Clinical Trials in the Therapeutic BTX Market, Global
• Emerging Products for the Therapeutic BTX Market, Global
• Geographies Covered, Global
• Average Currency Exchange Rates
• Therapeutic BTX Procedures Covered, US
• Approved Indications, by Brand, US, 2022/2023
• Therapeutic BTX Procedures Covered, Europe
• Approved Indications, by Brand, Europe, 2022/2023
• Therapeutic BTX Procedures Covered, Asia Pacific
• Approved Indications, by Brand, Asia Pacific, 2022/2023
• Therapeutic BTX Product Overview, Global, 2022/2023
• Global Therapeutic Botulinum Toxin Market Drivers
• Global Therapeutic Botulinum Toxin Market Limiters
• Therapeutic BTX Market, by Region, Global (USD), 2019-2033
• Therapeutic BTX Product Overview, Global, 2022/2023
• Mean Dosages, by Indication and Brand, Global
• BTX Units Used per Procedure, by Indication, Global
• BTX Product Equivalencies, by Brand
• Approved Indications, by Brand, US, 2022/2023
• Approved Indications, by Brand, Europe, 2022/2023
• Approved Indications, by Brand, Asia Pacific, 2022/2023
• Therapeutic BTX Procedures, by Indication, Global, 2019-2033
• Therapeutic BTX Procedures, by Region, Global, 2019-2033
• Therapeutic BTX Market, by Indication, Global (USD), 2019-2033
• Therapeutic BTX Market, by Region, Global (USD), 2019-2033
• Therapeutic BTX Market Growth, by Region, Global, 2019-2033
• Therapeutic BTX Revenue Market Shares, Global, 2023
• Therapeutic BTX Revenue Market Shares, by Region, Global, 2023
• Allergan (an AbbVie company) Competitive Insights
• Merz Pharma Competitive Insights
• Ipsen Competitive Insights
• GlaxoSmithKline Competitive Insights
• Supernus Pharmaceuticals Competitive Insights
• Competitive Insights for Other Key Competitors
• Recent Events in the Therapeutic BTX Market, Global
• Key Clinical Trials in the Therapeutic BTX Market, Global
• Emerging Products for the Therapeutic BTX Market, Global
• US Therapeutic Botulinum Toxin Market Drivers
• US Therapeutic Botulinum Toxin Market Limiters
• Therapeutic BTX Market, US (USD), 2019-2033
• Therapeutic BTX Procedures, by Indication, US, 2019-2033
• Spasticity Therapeutic BTX Procedures, by Anatomy, US, 2019-2033
• Spasticity Therapeutic BTX Procedures, by Age Group, US, 2019-2033
• Overactive Bladder Therapeutic BTX Procedures, by Cause, US, 2019-2033
• Therapeutic BTX Market, by Indication, US (USD), 2019-2033
• Therapeutic BTX Market, US (USD), 2019-2033
• Therapeutic BTX Revenue Market Shares, US 2023
• Therapeutic BTX Revenue Market Shares, US, 2023
• European Therapeutic Botulinum Toxin Market Drivers
• European Therapeutic Botulinum Toxin Market Limiters
• Therapeutic BTX Market, by Country, Europe (USD), 2019-2033
• Therapeutic BTX Procedures, by Indication, Europe, 2019-2033
• Therapeutic BTX Procedures, by Country, Europe, 2019-2033
• Therapeutic BTX Procedures, by Indication, France, 2019-2033
• Therapeutic BTX Procedures, by Indication, Germany, 2019-2033
• Therapeutic BTX Procedures, by Indication, Italy, 2019-2033
• Therapeutic BTX Procedures, by Indication, Spain, 2019-2033
• Therapeutic BTX Procedures, by Indication, UK, 2019-2033
• Therapeutic BTX Market, by Indication, Europe (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Country, Europe (USD), 2019-2033
• Therapeutic BTX Market, by Country, Europe (EUR and GBP), 2019-2033
• Therapeutic BTX Market Growth, by Country, Europe, 2020-2033
• Therapeutic BTX Market, by Indication, France (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Indication, Germany (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Indication, Italy (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Indication, Spain (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Indication, UK (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Indication, UK (GBP), 2019-2033
• Therapeutic BTX Revenue Market Shares, Europe, 2023
• Therapeutic BTX Revenue Market Shares, by Country, Europe, 2023
• Asia Pacific Therapeutic Botulinum Toxin Market Drivers
• Asia Pacific Therapeutic Botulinum Toxin Market Limiters
• Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019-2033
• Therapeutic BTX Procedures, by Indication, Asia Pacific, 2019-2033
• Therapeutic BTX Procedures, by Country, Asia Pacific, 2019-2033
• Therapeutic BTX Procedures, by Indication, Australia, 2019-2033
• Spasticity Therapeutic BTX Procedures, by Anatomy, Australia, 2019-2033
• Spasticity Therapeutic BTX Procedures, by Age Group, Australia, 2019-2033
• Overactive Bladder Therapeutic BTX Procedures, by Cause, Australia, 2019-2033
• Therapeutic BTX Procedures, by Indication, Japan, 2019-2033
• Therapeutic BTX Market, by Indication, Asia Pacific (USD), 2019-2033
• Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019-2033
• Therapeutic BTX Market, by Indication, Australia (USD), 2019-2033
• Therapeutic BTX Market, Australia (USD), 2019-2033
• Therapeutic BTX Market, by Indication, Japan (USD), 2019-2033
• Therapeutic BTX Market, Japan (USD), 2019-2033
• Therapeutic BTX Revenue Market Shares, Asia Pacific, 2023
• Therapeutic BTX Revenue Market Shares, by Country, Asia Pacific, 2023